Transform your novel small molecules into best-in-class therapeutics

Bringing new drugs to market is one of pharma's greatest challenges, with only 10% of candidates succeeding and many promising molecules derailed by scale-up transitions, process optimization, and equipment compatibility issues.

For over 20 years, GL CHEMTEC has partnered with innovative pharmaceutical companies to overcome these critical challenges.

Our comprehensive CDMO services cover all phases of the drug development process, from discovery to manufacturing, including:

• Expert synthetic route development and optimization for complex molecules, from milligram to Pilot Plant scale
• Advanced R&D labs with analytical capabilities to ensure quality and regulatory compliance
• Quick and efficient Kilo lab scale-up for Tox batches and beyond
• Cutting-edge pilot plant facilities enabling seamless transition to large-scale manufacturing
• End-to-end project support from our North American facilities, with proven success in transforming APIs into best in class treatments
• ISO 9001:2015, ISO 13485:2016 and ISO Class 6 Cleanroom/GMP compliant

ISO Certifications

ISO 13485:2016 – Medical Device & Early Clinical Studies

ISO 9001:2015 – A Commitment to Quality and Traceability